מונטהלוקאסט אינובמד 5 מ"ג

Valsts: Izraēla

Valoda: ivrits

Klimata pārmaiņas: Ministry of Health

Aktīvā sastāvdaļa:

MONTELUKAST AS SODIUM 5 MG

Pieejams no:

INOVAMED LTD

ATĶ kods:

R03DC03

Zāļu forma:

CHEWABLE TABLETS

Ievadīšanas:

PER OS

Ražojis:

SYNTHON B.V., NETHERLANDS

Ārstniecības grupa:

MONTELUKAST

Ārstēšanas norādes:

Montelukast Inovamed is indicated in pediatric patients 6 to 14 years of age for the prophylaxis and chronic treatment of asthma including prevention of daytime and nighttime symptoms the treatment of aspirin-sensitive asthmatic patients and the prevention of exercise-induced bronchoconstriction.Montelukast Inovamed is effective alone or in combination with other agents used in the maintenance treatment of chronic asthma. Montelukast Inovamed and inhaled corticosteroids may be used concomitantly with additive effects to control asthma or to reduce the inhaled corticosteroid dose while maintaining clinical stability. Montelukast Inovamed is indicated for the relief of symptoms of seasonal allergic rhinitis in adults and pediatric patients 6 to 14 years of age.

Autorizācija datums:

2012-01-01